drugset / Trial / NCT01138098
Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study will evaluate the persistence of immunity to hepatitis B 10 to 11 years after vaccination with Infanrix hexa™ or Engerix™-B and also the ability to mount an immune response to the challenge dose of Engerix™-B.
Timeline
- Start
- 2010-06-07
- Primary completion
- 2010-11-26
- Completion
- 2010-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engerix-B | Vaccine | 10 ug | Intramuscular |